Literature DB >> 19666526

CD4+CD25-LAG3+ regulatory T cells controlled by the transcription factor Egr-2.

Tomohisa Okamura1, Keishi Fujio, Mihoko Shibuya, Shuji Sumitomo, Hirofumi Shoda, Shimon Sakaguchi, Kazuhiko Yamamoto.   

Abstract

Regulatory T cells (Tregs) are engaged in the maintenance of immunological self-tolerance and immune homeostasis. IL-10 has an important role in maintaining the normal immune state. Here, we show that IL-10-secreting Tregs can be delineated in normal mice as CD4(+)CD25(-)Foxp3(-) T cells that express lymphocyte activation gene 3 (LAG-3), an MHC-class-II-binding CD4 homolog. Although approximately 2% of the CD4(+)CD25(-) T cell population consisted of CD4(+)CD25(-)LAG3(+) T cells in the spleen, CD4(+)CD25(-)LAG3(+) T cells are enriched to approximately 8% in the Peyer's patch. They are hypoproliferative upon in vitro antigenic stimulation and suppress in vivo development of colitis. Gene expression analysis reveals that CD4(+)CD25(-)LAG3(+) Tregs characteristically express early growth response gene 2 (Egr-2), a key molecule for anergy induction. Retroviral gene transfer of Egr-2 converts naïve CD4(+) T cells into the IL-10-secreting and LAG-3-expressing phenotype, and Egr-2-transduced CD4(+) T cells exhibit antigen-specific immunosuppressive capacity in vivo. Unlike Foxp3(+) natural Tregs, high-affinity interactions with selecting peptide/MHC ligands expressed in the thymus do not induce the development of CD4(+)CD25(-)LAG3(+) Tregs. In contrast, the number of CD4(+)CD25(-)LAG3(+) Tregs is influenced by the presence of environmental microbiota. Thus, IL-10-secreting Egr-2(+)LAG3(+)CD4(+) Tregs can be exploited for the control of peripheral immunity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19666526      PMCID: PMC2729005          DOI: 10.1073/pnas.0906872106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

Review 1.  Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.

Authors:  Helena Tlaskalová-Hogenová; Renata Stepánková; Tomás Hudcovic; Ludmila Tucková; Bozena Cukrowska; Rája Lodinová-Zádníková; Hana Kozáková; Pavel Rossmann; Jirina Bártová; Dan Sokol; David P Funda; Dana Borovská; Zuzana Reháková; Jirí Sinkora; Jaroslav Hofman; Pavel Drastich; Alena Kokesová
Journal:  Immunol Lett       Date:  2004-05-15       Impact factor: 3.685

Review 2.  E3 ubiquitin ligases as T cell anergy factors.

Authors:  Daniel L Mueller
Journal:  Nat Immunol       Date:  2004-09       Impact factor: 25.606

3.  Emerging challenges in regulatory T cell function and biology.

Authors:  Shimon Sakaguchi; Fiona Powrie
Journal:  Science       Date:  2007-08-03       Impact factor: 47.728

4.  The CD4-related molecule, LAG-3 (CD223), regulates the expansion of activated T cells.

Authors:  Creg J Workman; Dario A A Vignali
Journal:  Eur J Immunol       Date:  2003-04       Impact factor: 5.532

5.  Lymphocyte activation gene-3 (CD223) regulates the size of the expanding T cell population following antigen activation in vivo.

Authors:  Creg J Workman; Linda S Cauley; In-Jeong Kim; Marcia A Blackman; David L Woodland; Dario A A Vignali
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

6.  Nucleosome-specific regulatory T cells engineered by triple gene transfer suppress a systemic autoimmune disease.

Authors:  Keishi Fujio; Akiko Okamoto; Hiroyuki Tahara; Masaaki Abe; Yi Jiang; Toshio Kitamura; Sachiko Hirose; Kazuhiko Yamamoto
Journal:  J Immunol       Date:  2004-08-01       Impact factor: 5.422

7.  Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10.

Authors:  Craig L Maynard; Laurie E Harrington; Karen M Janowski; James R Oliver; Carlene L Zindl; Alexander Y Rudensky; Casey T Weaver
Journal:  Nat Immunol       Date:  2007-08-12       Impact factor: 25.606

Review 8.  Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans.

Authors:  Maria-Grazia Roncarolo; Manuela Battaglia
Journal:  Nat Rev Immunol       Date:  2007-08       Impact factor: 53.106

9.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.

Authors: 
Journal:  Nature       Date:  2007-06-07       Impact factor: 49.962

10.  A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism.

Authors:  Janine L Coombes; Karima R R Siddiqui; Carolina V Arancibia-Cárcamo; Jason Hall; Cheng-Ming Sun; Yasmine Belkaid; Fiona Powrie
Journal:  J Exp Med       Date:  2007-07-09       Impact factor: 14.307

View more
  93 in total

Review 1.  Resolving the identity myth: key markers of functional CD4+FoxP3+ regulatory T cells.

Authors:  Xin Chen; Joost J Oppenheim
Journal:  Int Immunopharmacol       Date:  2011-05-31       Impact factor: 4.932

2.  Th17 cells express interleukin-10 receptor and are controlled by Foxp3⁻ and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner.

Authors:  Samuel Huber; Nicola Gagliani; Enric Esplugues; William O'Connor; Francis J Huber; Ashutosh Chaudhry; Masahito Kamanaka; Yasushi Kobayashi; Carmen J Booth; Alexander Y Rudensky; Maria Grazia Roncarolo; Manuela Battaglia; Richard A Flavell
Journal:  Immunity       Date:  2011-04-22       Impact factor: 31.745

Review 3.  Genetics of autoimmune diseases: perspectives from genome-wide association studies.

Authors:  Yuta Kochi
Journal:  Int Immunol       Date:  2016-02-08       Impact factor: 4.823

Review 4.  Calcium-NFAT transcriptional signalling in T cell activation and T cell exhaustion.

Authors:  Patrick G Hogan
Journal:  Cell Calcium       Date:  2017-01-28       Impact factor: 6.817

Review 5.  Type 1 regulatory T cells: a new mechanism of peripheral immune tolerance.

Authors:  Hanyu Zeng; Rong Zhang; Boquan Jin; Lihua Chen
Journal:  Cell Mol Immunol       Date:  2015-06-08       Impact factor: 11.530

6.  Key role of macrophages in tolerance induction via T regulatory type 1 (Tr1) cells.

Authors:  B Mfarrej; T Jofra; C Morsiani; N Gagliani; G Fousteri; M Battaglia
Journal:  Clin Exp Immunol       Date:  2020-05-13       Impact factor: 4.330

Review 7.  Induction and stability of the anergic phenotype in T cells.

Authors:  Rut Valdor; Fernando Macian
Journal:  Semin Immunol       Date:  2013-11-05       Impact factor: 11.130

Review 8.  Regulatory circuits of T cell function in cancer.

Authors:  Daniel E Speiser; Ping-Chih Ho; Grégory Verdeil
Journal:  Nat Rev Immunol       Date:  2016-08-16       Impact factor: 53.106

9.  Investigation of immune cell markers in feline oral squamous cell carcinoma.

Authors:  Ellen E Sparger; Brian G Murphy; Farina Mustaffa Kamal; Boaz Arzi; Diane Naydan; Chrisoula T Skouritakis; Darren P Cox; Katherine Skorupski
Journal:  Vet Immunol Immunopathol       Date:  2018-06-13       Impact factor: 2.046

10.  A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis.

Authors:  Carlos Riveros; Drew Mellor; Kaushal S Gandhi; Fiona C McKay; Mathew B Cox; Regina Berretta; S Yahya Vaezpour; Mario Inostroza-Ponta; Simon A Broadley; Robert N Heard; Stephen Vucic; Graeme J Stewart; David W Williams; Rodney J Scott; Jeanette Lechner-Scott; David R Booth; Pablo Moscato
Journal:  PLoS One       Date:  2010-12-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.